Vedolizumab-Associated Drug-Induced Liver Injury: A Case Series

Inflamm Bowel Dis. 2021 Feb 16;27(3):e32-e34. doi: 10.1093/ibd/izaa286.

Authors

Sailish Honap^{1

2}, Eva Sticova³, Eleni Theocharidou⁴, Philip Berry⁴, Peter M Irving^{1

2}, Mark A Samaan¹, Sreelakshmi Kotha⁴

Affiliations

¹ IBD Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.
² School of Immunology and Microbial Sciences, King's College London, London, UK.
³ Institute of Liver Studies, King's College London, London, UK.
⁴ Department of Hepatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.

PMID: 33155638
DOI: 10.1093/ibd/izaa286

No abstract available

Keywords: cholestasis; drug-induced liver injury; hepatitis; vedolizumab.

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized* / adverse effects
Chemical and Drug Induced Liver Injury* / etiology
Humans
Liver

Substances

Antibodies, Monoclonal, Humanized
vedolizumab